Henry Kaplan
Henry G. Kaplan, M.D.

Henry G. Kaplan, M.D.

Henry G. Kaplan, M.D.
Specialty

Hematology, Oncology - Medical, Oncology - Medical: Swedish Cancer Institute

Clinical Interests / Special Procedures Performed

Breast Cancer, Clinical Research & Educ., Clinical Trials, Lymphoma, Myeloma

  • Accepting Children: No
  • Accepting New Patients: Yes
  • Accepting Medicare: Yes
  • Accepting Medicaid/DSHS: Yes
Payment Methods Accepted:

Medicare, Medicaid/DSHS, Bill Insurance, VISA, Master Card, Cash, Check, American Express, Discover Card, Money Order

Insurance Accepted:

Contact this office for accepted insurance plans.

Additional Information:

Chief Residency, Dept of Medicine: University of Washington, WA Clinical Associate Professor, University of Washington. Clinical Professor of Medicine Brown University 1977-79, Adjunct Professor of Pharmacy, University of Rhode Island 1977-79, Assistant Professor of Medicine, University of WAshington 1979-1981.


 

Dr. Kaplan was voted "Top Doctors" in Seattle Metropolitan Magazine (2011, 2013)

Physicians, nurses and physician assistants in King, Kitsap and Snohomish counties nominated colleagues they would choose to treat themselves and their loved ones.

News Release

Dr. Kaplan was voted "Top Doctors" in Seattle Magazine (2013)

Surveys were mailed to physicians in King, Pierce, Snohomish and Kitsap counties. The survey asked physicians to name the provider they would seek out or recommend to loved ones.

News Release

Philosophy of Care

Try to help the patient make the most of life

Personal Interests

hiking, backpacking, photography

Medical School

University of Rochester, NY

Residency

University of Washington, WA

Fellowship(s)

National Cancer Institute/National Institutes of Health - Clinical Associate

Board Certifications

Internal Medicine; Oncology

Languages:

English

Professional Associations:

AOA,ASCO, AACR,ASBD,NS Society, AMA, WSMA

Awards:

multiple faculty teaching awards, Swedish Physician Recognition Award,AOA

Additional Information:

Chief Residency, Dept of Medicine: University of Washington, WA Clinical Associate Professor, University of Washington. Clinical Professor of Medicine Brown University 1977-79, Adjunct Professor of Pharmacy, University of Rhode Island 1977-79, Assistant Professor of Medicine, University of WAshington 1979-1981.


 

Dr. Kaplan was voted "Top Doctors" in Seattle Metropolitan Magazine (2011, 2013)

Physicians, nurses and physician assistants in King, Kitsap and Snohomish counties nominated colleagues they would choose to treat themselves and their loved ones.

News Release

Dr. Kaplan was voted "Top Doctors" in Seattle Magazine (2013)

Surveys were mailed to physicians in King, Pierce, Snohomish and Kitsap counties. The survey asked physicians to name the provider they would seek out or recommend to loved ones.

News Release

CLINICAL TRIALS:

Dr. Henry Kaplan is the lead investigator for the following clinical trials currently available at the Swedish Cancer Institute:

I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2)

"PRESENT": Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax™ Treatment

A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy

A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma
________________________________________

PUBLICATIONS:

Ryu RJ, Eyal S, Kaplan HG, Akbarzadeh A, Hays K, Puhl K, Easterling TR, Berg SL, Scorsone KA, Feldman EM, Umans JG, Miodovnik M, Hebert MF. Ryu RJ, Eyal S, Kaplan HG, Akbarzadeh A, Hays K, Puhl K, Easterling TR, Berg SL, Scorsone KA, Feldman EM, Umans JG, Miodovnik M, Hebert MF. Pharmacokinetics of doxorubicin in pregnant women.  Cancer Chemother Pharmacol. 2014 Apr; 73(4):789-97.
 
Kaplan HG. Vemurafenib treatment of BRAF V600E-mutated malignant peripheral nerve sheath tumor  J Natl Compr Canc Netw. 2013 Dec 1;11 (12):1466-70.
 
Kaplan HG, Malmgren JA, Li CI, Calip GS. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors. Breast Cancer Res Treat. 2013 Dec; 142(3):629-36.
 
Kaplan HG, Malmgren JA, Atwood MK.  Adjuvant chemotherapy and differential invasive breast cancer specific survival in elderly women. J Geriatr Oncol. 2013 Apr;4(2):148-56. doi: 10.1016/j.jgo.2012.12.007. Epub 2013 Jan 23.
 
Nassiri F, Scheithauer BW, Corwin DJ, Kaplan HG, Mayberg M, Cusimano MD, Rotondo F, Kovacs K.  Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013 Jun 1;4:74.
 
Kaplan HG, Malmgren JA. The breast cancer overdiagnosis conundrum: an oncologist's viewpoint. Ann Intern Med. 2013 Jan 1;158(1):60-1.
 
Yee D, Haddad T, Albain K, Barker A, Benz C, Boughey J, Buxton M, Chien AJ, DeMichele A, Dilts D, Elias A, Haluska P, Hogarth M, Hu A, Hytlon N, Kaplan HG, Kelloff GG, Khan Q, Lang J, Leyland-Jones B, Liu M, Nanda R, Northfelt D, Olopade OI, Park J, Parker B, Parkinson D, Pearson-White S, Perlmutter J, Pusztai L, Symmans F, Rugo H, Tripathy D, Wallace A, Wholley D, Van't Veer L, Berry DA, Esserman L. Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development. J Clin Oncol. 2012 Dec 20;30(36):4584-6. 

Malmgren JA, Parikh J, Atwood MK, KAPLAN HG. Impact of mammography detection on the course of breast cancer in women aged 40-49 years. Radiology. 2012 Mar; 262(3):797-806.

KAPLAN, H.G., Malmgren, J.A., and Atwood, M.K.: “Increased Incidence of Myelodysplastic Syndrome and Acute Myeloid Leukemia Following Breast Cancer Treatment with Radiation Alone or In Combination with Chemotherapy: A Registry Cohort Analysis 1990-2005,” BMC Cancer 11:260; 2011.

Malmgren, J.A., Atwood, M.K., and KAPLAN, H.G.: “Mammography Detected Breast Cancer Over Time Among Patients 75 and Older at a Community Based Cancer Center:1990-2008,” Amer Soc Clin Onc, 29(15S):#9086;2011.

KAPLAN, H.G., Malmgren, J.A., Atwood, M, Goldstein, L.C.: “Positive Response to Neoadjuvant Cyclophosphamide and Doxorubicin in Topoisomerase II Non-Amplified/Her2/neu negative/Polysomy 17 Absent Breast Cancer Patients,” Cancer Mgmt & Res, 2:213-218;2010.

KAPLAN, H.G., Malmgren, J.A., and Atwood, M.: “T1N0 Triple Negative Breast Cancer: Risk Recurrence and Adjuvant Chemotherapy,” Breast J 15(5):454-460; 2009.

Witzig, T.E., Wiernik, P.H., Moore, T., Reeder, C., Coe, C., Justice, G., KAPLAN, H., Voralia, M., Pietronigro, D., Takeshita, K., Ervin-Hayes, A., Zeldis, J.B., and Vose, J.M.: “Phase II Multi-Center Study of Lenalidomide Oral Monotherapy in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma,” J Clin Onc, 27(32):5404-9;2009.

Malmgren, J.A., Atwood, M., and KAPLAN, H.: “Increase in Mammography Detected Breast Cancer Over Time at a Community Based Regional Cancer Center: A Longitudinal Cohort Study, 1990 – 2005,” BMC Cancer 8:131-7;2008.

Vemulakonda, V.M., Lendvay, T.S., Shnorhavorian, M., Joyner, B.D., KAPLAN, H., Mitchell, M.E., and Grady, R.W.: “Metastatic Adenocarcinoma after Augmentation Gastrocystoplasty, J Urology 179(3):1094-7;2008.

KAPLAN, H.G., and Malmgren, J.A.: “Impact of Triple Negative Phenotype on Breast Cancer Prognosis,” Breast J 14(5):456-463;2008.

KAPLAN, H.G., Malmgren, J.A., and Atwood, M.: “Impact of Detection Method on the Course of Breast Cancer: Patient versus Mammography Detected,” Clin. Breast Cancer, 7(2):133-140;2006.

KAPLAN, H.G., Malmgren, J.A., and Atwood, M.: “Leukemia Incidence Post Primary Breast Cancer Treatment,” Cancer 101:1529-1536; 2004.

Perez, E., Navari, R.M., KAPLAN, H.G., Gralla, R.J., Grunberg, S.M., Palmer, R., and Fitts, D.: “Antiemetic Efficacy and Safety of Different Doses of Granisetron in Patients Receiving Platinum,” Support. Care Cancer 5:31; 1997.

Navari, R.M., KAPLAN, H.G., Gralla, R.J., Grunberg, S.M., Palmer, R., and Fitts, D.: “Efficacy and Safety of Granisetron, A Selective 5-HT3 Antagonist, In the Prevention of Nausea and Vomiting Induced by High Dose Platinum,” J. Clin. Oncol. 12:2204; 1994.

KAPLAN, H.G.: “Cancer Chemotherapy in the Elderly,” in Vestal, R., ed., Drug Therapy in the Elderly, Addis Press, Auckland, 1984, pp. 338-350.

Larson, E.B., Scott, D.H., and KAPLAN, H.G.: “Inadequate Medical Order Writing – A Source of Confusion and Increased Costs,” Western J. Med. 139:50; 1983.

Wiemann, M.C., Cummings, F.J., KAPLAN, H.G., Spermuli, E.N., Doolittle, C.H., and Calabresi, P.: “Clinical and Pharmacological Studies of Methotrexate-Minimal Leucovorin Rescue Plus 5-Fluorouracil,” Cancer Res. 42:3896; 1982.

KAPLAN, H.G., Appelbaum, F.R., Cheever, M.A., Greenberg, P.D., Wood, T., and Fefer, A.: “Treatment of Refractory Acute Non-Lymphocytic Leukemia with A Combination of Pyrazofuran and Cytosine Arabinoside,” Cancer Treat. Rep. 66:1397; 1982.

Fefer, A., Cheever, M.A., Greenberg, P.D., Appelbaum, F.R., Boyd, C.N., Buckner, C.D., KAPLAN, H.G., Ramberg, R., Sanders, J.E., Storb, R., and Thomas, E.D.: “Treatment of Chronic Granulocytic Leukemia with Chemoradiotherapy and Transplantation of Marrow from Identical Twins.” New England J. Med. 306:63; 1982.

Appelbaum, F.R., Fefer, A., Cheever, M.A., Buckner, C.D., Greenberg, P.D., KAPLAN, H.G., Storb, R., and Thomas, E.D.: “Treatment of Non-Hodgkin’s Lymphoma with Marrow Transplantation in Identical Twins,” Blood 58:509; 1981.

Larson, S.M., Weiden, P.L., Grunbaum, Z., KAPLAN, H.G., Rasey, J.S., Graham, M.M., Sale, G.E., Harp, G., and Williams, D.L.: “Positron Imaging Feasibility Studies II: Characteristics of 2-Deoxyglucose Uptake in Rodent and Canine Neoplasms,” J. Nucl. Med. 22:881; 1981.

Larson, S.M., Weiden, P.L., Grunbaum, Z., Rasey, J.S., KAPLAN, H.G., Graham, M.M., Harp, G., Sale, G.E., and Williams, D.L.: “Positron Imaging Feasibility Studies I: Characteristics of 3H-Thymidine Uptake in Rodent and Canine Neoplasms,” J. Nucl. Med. 22:875; 1981.

Fefer, A., Cheever, M.A., Thomas, E.D., Appelbaum, F.R., Buckner, C.D., Clift, R.A., Glucksberg, H., Greenberg, P.D., Johnson, F.L., KAPLAN, H.G., Sanders, J.E., and Storb, R.: “Bone Marrow Transplantation for Refractory Acute Leukemia in 34 Patients with Identical Twins,” Blood 57:421; 1981.
KAPLAN, H.G.: “Inhibition of Buttermilk Xanthine Oxidase by Folate Analogues And Derivatives,” Biochem. Pharmacol. 29:2135; 1980.

KAPLAN, H.G., and Doolittle, C.: “Hodgkin’s Disease Presenting as Steroid-Dependent Pancytopenia,” Cancer 45:3114; 1980.

KAPLAN, H.G., Bakken, J., Quadracci, L., and Schubach, W.: “Hepatitis Caused by Repeated Sniffing of Halothane,” Annals Int. Med. 97:797; 1979.

Cummings, F.J., Stoller, R.G., KAPLAN, H.G., and Calabresi, P.: “A Clincial Study of Pyrazofuran,” Cancer Treat. Rep. 63:1363; 1979.

Stoller, R.G., KAPLAN, H.G., Cummings, F.J., and Calabresi, P.: “A Clinical and Pharmacological Study of High-Dose Methotrexate with Minimal Leucovorin Rescue,” Cancer Res. 39:908; 1979.

KAPLAN, H.G., and Myers, C.E.: “Complex Inhibition of Thymidylate Synthetase By Aromatic Diamidines: Evidence for Both Rapid, Freely Reversible and Slowly Progressive Non-Equilibrium Inhibition,” J. Pharm. Exptl. Therap.201:554; 1977.

Friedman, J, KAPLAN, H., and Hall, J.: “The Jeune Syndrome (Asphyxiating Thoracic Dystrophy) in an Adult,” Amer. J. Med. 59:875; 1975.

Miller, D.R., and KAPLAN, H.G.: “Reduced NBT Dye Reduction in Phagocytes Of Patients Receiving Prednisone,” Pediatrics 45:861; 1970.

Offices

Medical Oncology / First Hill - Swedish Cancer Institute
1221 Madison Street
Arnold Pavilion, Suite 200
Seattle, WA 98104
Phone: 1-(855)-XCANCER (1-855-9226237) or (206) 215-3600

Map & Directions

Swedish Cancer Institute - Medical Oncology
True Family Women's Cancer Center
1221 Madison St., 5th Floor
Seattle, WA 98104
Phone: 206-386-2828
Fax: 206-386-3782

Map & Directions

Physicians: Is this your profile? Click here for info